Selected Drugs Clear All
MultiCheck Results
- 0
Interaction
Additional Considerations |
||
|
rozanolixizumab
in Rystiggo (rozanolixizumab-noli)
|
||
|
consider alternative to rozanolixizumab with long-term use of drugs that bind to human neonatal Fc receptor (FcRn) (e.g., immunoglobulin products, monoclonal antibodies, or antibody derivates containing the human Fc domain of the IgG subclass); FcRn blockade may decr. systemic exposure, efficacy of such medications |
||